Prognosis and treatment of uterine sarcoma found incidentally after myomectomy
European Journal of Surgical Oncology · 2024
DOI: 10.1016/j.ejso.2024.108652 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2024. Verfasst von Hua Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: Uterine Neoplasms, Uterine Myomectomy, Incidental Findings, Sarcoma. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Cancer Hospital Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
OBJECTIVE: To determine prognosis and factors associated with survival of women with uterine sarcoma found incidentally after myomectomy. METHODS: We performed a retrospective study for patients who had previously undergone myomectomy for presumed benign uterine fibroid disease and were found to have uterine confined sarcoma after myomectomy surgery. RESULTS: In total, 50 patients were identified. There were 23 (46.0 %) patients undergoing myomectomy were performed by minimal invasive surgery: laparoscopic (Lap, n = 22, 44.0 %) or transvaginal (TV, n = 1, 2.0 %) approach; while, 24 (48.0 %) and 3 (6.0 %) patients had myomectomy through abdominal (Abd) or hysteroscopic (Hys) approach. All patients received the re-exploration and staging surgery in our center. The median time from myomectomy to the staging surgery was 43 days (range 15-90 days). 17 patients had remnant sarcomas on the remaining uterus and 6 patients had disseminated disease after re-exploration. In the entire cohort, 5-year RFS and 5-year OS was 79.4 % and 88.0 %, respectively. Patients who received initial Lap/TV myomectomy had a tendency towards a worse 5-year RFS compared with Abd/Hys approach (63.0 % vs 88.9 %, P = 0.080). No difference in 5-year OS was found between the two groups (90.3 % vs 91.8 %, P = 0.768). For stage I disease (n = 44), patients who received Lap/TV myomectomy had a worse 5-year RFS compared with Abd/Hys approach (58.3 % vs 95.7 %, P = 0.009). No difference in 5-year OS was found (P = 0.121). CONCLUSION: Patients with incidental uterine sarcoma who received primary Lap/TV myomectomy may have a worse RFS. Re-exploration can detect remnant or disseminated sarcomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Elec…
Förderung
- Cancer Hospital Chinese Academy of Medical Sciences
Zitieren
APA
Yuan, H., Li, N., Wu, L., & Yao, H. (2024). Prognosis and treatment of uterine sarcoma found incidentally after myomectomy. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.108652
Vancouver
Yuan H, Li N, Wu L, Yao H. Prognosis and treatment of uterine sarcoma found incidentally after myomectomy. European Journal of Surgical Oncology. 2024. doi:10.1016/j.ejso.2024.108652
BibTeX
@article{Yuan2024,
author = {Yuan, Hua and Li, Ning and Wu, Lingying and Yao, Hongwen},
title = {Prognosis and treatment of uterine sarcoma found incidentally after myomectomy},
journal = {European Journal of Surgical Oncology},
year = {2024},
doi = {10.1016/j.ejso.2024.108652}
}
EUVIMED